Warner-Lambert consumer health care sales up 18% in 2nd quarter.
This article was originally published in The Tan Sheet
Executive SummaryWARNER-LAMBERT INTERNATIONAL OPERATIONS BOOSTED CONSUMER HEALTH CARE SALES, which grew 18% to $801 mil. in the second quarter, the company reported July 20. Consumer health care sales outside the U.S. (including Warner Wellcome sales in international markets) increased 35% to $456 mil. while U.S. consumer sales grew 1% to $345 mil. Sales of Halls cough tablets increased 15% to $93 mil. in the second quarter
You may also be interested in...
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.
With just under 120 days until the full application of the EU’s Medical Device Regulation, and fears growing of the loss of products seen as non-compliant, the EU medtech industry has identified a way of broadening the application of the “grace period.” It is a legal way of addressing the potential loss of tens of thousands of products come 26 May, says MedTech Europe’s Oliver Bisazza.